HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Calcium antagonist isradipine reduces metabolic alterations in acute cerebral ischemia in spontaneously hypertensive rats.

Abstract
The present study was designed to examine the effect of a calcium antagonist isradipine (PN200-110: PN) on local cerebral blood flow and brain tissue metabolism after 1-hour supratentorial ischemia induced by bilateral carotid artery ligation (BCL) in spontaneously hypertensive rats (SHR). PN, dissolved in ethanol plus polyethylene glycol 400, diluted with saline to make the final concentration of 0.25mg/ml and 2.5mg/ml, was administered subcutaneously either 30 min prior to BCL or just after the induction of incomplete cerebral ischemia (n = 7 in each group). Vehicle injection was served as a control group (n = 7). Cerebral blood flow in the parietal cortex (CBF) and the cerebellar cortex (CeBF) was measured by hydrogen clearance technique, and the supra- and infratentorial metabolites of the brain frozen in situ were determined by the enzymatic method. Blood pressure was lowered, but CBF was increased by PN administration in pre-BCL treatment study. After 1 hour of BCL, CBF decreased to around 10% or less of the resting value, being insignificant among the groups. Brain adenosine triphosphate was better preserved in PN-administered groups. The increase in lactate level tended to reduce dose dependently by PN treatment. PN also reduced the metabolic alterations in brain tissue with significance, even when administered just after the induction of forebrain ischemia. It is considered that pre- as well as post-BCL administration of PN is beneficial to attenuate the metabolic alterations in incomplete forebrain ischemia in SHR.
AuthorsS Ibayashi, T Nagao, T Kitazono, H Ooboshi, J Kitayama, S Sadoshima, M Fujishima
JournalNeurochemical research (Neurochem Res) Vol. 25 Issue 3 Pg. 349-55 (Mar 2000) ISSN: 0364-3190 [Print] United States
PMID10761978 (Publication Type: Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Isradipine
Topics
  • Acute Disease
  • Animals
  • Arterial Occlusive Diseases (complications)
  • Brain (drug effects, metabolism)
  • Calcium Channel Blockers (pharmacology)
  • Carotid Artery Diseases (complications)
  • Carotid Artery, Common
  • Cerebrovascular Circulation (drug effects)
  • Female
  • Ischemic Attack, Transient (etiology, metabolism, physiopathology)
  • Isradipine (pharmacology)
  • Rats
  • Rats, Inbred SHR

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: